
HONLIV HEALTH released its interim results, with a loss attributable to shareholders of RMB 673,000, turning from profit to loss year-on-year

I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, HONLIV HEALTH released its mid-term results for 2025, with revenue of 347 million yuan (RMB, the same below), a year-on-year decrease of 16.5%; the loss attributable to shareholders was 673,000 yuan, compared to a profit attributable to shareholders of 20.042 million yuan in the same period last year, turning from profit to loss year-on-year
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

